The Consumer Price Index (CPI) for July was released this morning. Economists had expected to see an increase of 3% year-over-year, the same rate as June, with core CPI expected to fall to 3.2% from 3.3% in June, its lowest level since 2021. Family-owned candy giant Mars is set to acquire Kellenova (K) in a massive deal worth nearly $36 billion. Kellenova brands include Pringles, Eggo, and Pop-Tarts. Trending Tickers on Yahoo Finance include Starbucks (SBUX), Chipotle (CMG), and UBS Group (UBS).
Top guests today include: 8:35 AM: Nathan Sheets, Citi Chief Global Economist & Nicholas Brooks, ICG Head of Economics and Investment Research 8:45 AM: David Rogal, BlackRock Portfolio Manager, Fundamental Fixed Income Group 9:05 AM: Mark Zandi, Moody’s Analytics Chief Economist 9:30 AM: Brent Thill, Jefferies Senior Analyst 9:45 AM: Krishna Guha, Evercore ISI Vice Chairman 9:50 AM: Bill Baer, Former US Assistant Attorney General of the Antitrust Division 10:15 AM: Aaron Alt, Cardinal Health CFO 11:00AM: Ken Mahoney, Mahoney Asset Management CEO 11:30 AM: Richard Gelfond, IMAX CEO
Covering the cost of fertility treatment can feel like yet another hurdle in a process that is already physically and emotionally draining. Not only do you have to go through the testing and medical procedures involved, you can also end up paying tens or even hundreds of thousands of dollars.
For families who want to have kids or women who want to afford themselves a little more time, though, this can feel like a price well worth paying. But the process may necessitate some financial planning. Research can also go a long way, as insurance companies increasingly offer coverage.
How much can fertility treatments cost?
The cost of fertility treatments can vary widely depending on the specific treatment that is necessary. A “typical egg preservation cycle is about $10,000,” while a frozen embryo transfer “could total about $2,500,” said The Bump. Meanwhile, a procedure like in vitro fertilization (IVF) “could add up to a total of $13,000 to $14,000.” Opting for a surrogate, meanwhile, can run anywhere from $80,000 to $100,000.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
SUBSCRIBE & SAVE
Advertisement
Sign up for The Week’s Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Latest Videos From
There is also the reality that a fertility treatment is not always a one-time thing. In fact, “most people will need more than one cycle to achieve pregnancy,” said The Wall Street Journal.
Can insurance help cover fertility treatments?
Over the past decade, “more companies have already stepped up to help employees,” said Jaime Knopman, a reproductive endocrinologist for CCRM Fertility of New York, to the Journal. Now, said the outlet, “more than 40% of companies offer overall fertility benefits, according to a 2024 survey of employee benefits plans from the International Foundation of Employee Benefit Plans.”
Still, this does not mean you will get full coverage, and certain parts of the treatment process may not be covered. For example, “your plan may cover fertility medications, but only those of a specific brand. Or it may cover routine lab work, but only at designated labs,” said Discover. This makes it absolutely vital to do in-depth research and ask questions.
Advertisement
If your company does not offer coverage, it could be worth asking HR. “Some patients even successfully lobbied their human-resources departments to change a company’s policies and benefits plans,” said the Journal.
Join 350,000+ subscribers and keep yourself informed with a selection of
The Week’s most interesting, enlightening and entertaining stories – plus daily puzzles.
What are other options for covering the cost of treatments?
There are options besides your own bank account or insurance for helping to cover the cost of fertility treatments. Some alternatives include:
FSA or HSA funds: Flexible spending accounts, or FSAs, and health savings accounts, or HSAs, “may be used to help pay for IVF and other fertility treatments,” said First Citizens Bank.
Provider payment plans or financial assistance: Your doctor “may offer a payment plan, discounts for uninsured patients or even a shared-risk program,” said Discover.
Advertisement
Nonprofits and charities: There are many “national and local nonprofit organizations that support fertility treatments and related costs,” said Discover. They may have eligibility requirements, however, as some are “established to assist with specific types of patients, while many include income thresholds.”
Fifty years ago, the U.S. Supreme Court struck down campaign spending limits in the landmark decision Buckley v. Valeo, finding the curbs violated First Amendment free-speech protections. Since then, several rulings, including the 2010 Citizens United case, which ended restrictions on election donations by corporations, nonprofits, and labor unions, have further loosened campaign finance regulations.
In this interview, which has been edited and condensed for length and clarity, Nicholas Stephanopoulos, Kirkland & Ellis Professor of Law at Harvard Law School, spoke about the recent ruling by the Supreme Court that lifted restrictions on how much money political parties can spend in coordination with candidates, its downside and potential upside, and its possible impact on the midterm elections.
Can you explain what the recent campaign finance ruling means? How is it going to affect political parties?
The recent decision is a not a huge blockbuster like some other campaign finance cases we’ve seen in recent years. That’s because the decision only involves limits on political parties’ coordinated expenditures with candidates, and that pool of money, both today and potentially in the future, is not enormous.
Before this ruling, parties could spend whatever they want, even before they could coordinate a lot of expenditures with candidates. Now they can just coordinate somewhat more. So, the stakes here were sort of moderate.
Advertisement
The two things the decision means above all are these: On the negative side, it’ll be easier now for a corrupt donor [to skirt individual donation limits] to funnel more money to a candidate using a party as the conduit or the vehicle for that contribution. On the positive side, parties are permanent, important political institutions, and now somewhat more money might flow to parties instead of super PACs and dark money groups and other more problematic organizations.
Nicholas Stephanopoulos.
Harvard Law School
Justice Elena Kagan, who dissented from this ruling, said this decision would increase the likelihood of “political corruption.” Do you agree?
First of all, notice that Kagan isn’t challenging the fundamentals of campaign finance law. She’s not claiming that money isn’t speech. She’s not claiming that all campaign finance regulations should be upheld. She’s fully arguing within the current court’s doctrinal framework. She thinks that the law at issue is necessary to prevent corruption.
Advertisement
Kagan points out that, with a little bit of bookkeeping, it should be fairly straightforward now for a donor to give effectively half a million dollars to a candidate channeled through a party, as opposed to the $7,000 the donor is allowed to give directly to the candidate.
With much bigger sums that can now be given through a party to a candidate, there’s the possibility of more quid pro quo corruption. A candidate isn’t likely to do very much in return for $7,000 but a candidate may do quite a bit more in return for $500,000. So I think we’ll see somewhat more corruption in politics as a result of today’s decision.
What’s the idea behind “money is speech,” which has been at the core of most campaign finance decisions since the 1970s?
The premise that money is speech, or at least it enables political speech, means that it can be covered by the First Amendment. That premise underlies all campaign finance doctrine since the 1970s.
It’s a controversial doctrine. Individual justices over the years have pointed out that money is not speech, and merely enabling speech is not the same thing as being speech itself. All campaign finance decisions since the 1970s have assumed that regulations of political funding involved the First Amendment because there’s a close enough connection to political speech, and even the progressive justices in the 1990s and 2000s still accepted that the First Amendment was involved here.
Advertisement
The implication of fully endorsing the position that money isn’t speech is that all of these cases would quickly fall by the wayside. If money isn’t speech and there’s no First Amendment issue presented here, then Congress can regulate campaign finance however Congress wants to, without any possible First Amendment problem. But that view has never been the view of the majority of the court.
Can you compare the impact of this recent ruling to that of the 2010 Citizens United case?
Citizens United involved independent spending by corporations, by unions, and the court said that there’s no valid justification for limiting any independent campaign spending, whether it’s by candidates, rich individuals, parties, corporations, or unions.
The current case involves the somewhat less-explosive issue of coordinated expenditures. Citizens United was a sweeping decision, striking down a very important federal law and opening the door to huge new sums to be spent in politics. This decision isn’t like that. It doesn’t involve independent spending. It only involves one actor, political parties, not the whole range of actors. The stakes are a lot lower than the Citizens United case.
With this ruling, the Supreme Court overruled a 2001 decision, which upheld the same limits on coordinate expenditures with candidates. How do you explain that?
Advertisement
The 2001 case was decided by the court when it was at its most pro-regulatory in the campaign finance context. What changed since 2001 is the composition of the court.
The critical change was when Sandra Day O’Connor retired in 2006, and Sam Alito replaced her. Alito has always been a skeptic of campaign finance regulations, whereas O’Connor, especially toward the end of her time on the court, was willing to uphold a lot of campaign finance regulations.
Almost everything that’s followed since then, Citizens United in 2010, McCutcheon in 2014, and other decisions striking down campaign finance laws, happened not because the world of politics changed or because there was some big insight on the court. It happened because the court became more conservative and what had been a five-four pro-regulation majority became a five-four anti-regulation majority.
It’s no surprise that the current court, which is now six-three against campaign finance regulation, doesn’t like a decision from this earlier period.
Will this ruling impact the midterm elections?
Advertisement
In the near term, this will somewhat benefit the Republican Party committees that have more funds at their disposal because they have just happened to raise a lot more money recently than the Democratic Party entities.
However, even before this decision, all of those Republican entities could still spend their money however they wanted to, so it’s not that big of a change for them. I think Democrats will direct more of their donors to give some more money to party organizations. There might be a short-term benefit for Republicans, but I don’t think this will cause a great imbalance in the system going forward.
Overall, I’m not incredibly alarmed by this ruling. We’re still going to have in place various other laws and precautions that will stop some corruption.
It’s bad for our system to allow super PACs and dark-money groups to become the leading actors in campaign finance. I’d rather have the money in parties’ hands than in super PACs or dark-money groups’ hands. I don’t think the doors are really open for that much additional corruption here. I think there’s a non-trivial silver lining in strengthening political parties, which are valuable institutions.
Breaking a six-month record, the investment banking giant capitalizes on a surging wave of global megadeals.
Goldman Sachs said it had advised on more than $1 trillion of announced global mergers and acquisitions so far this year, the fastest any investment bank has reached that milestone in a six-month period, citing data from capital markets data provider Dealogic.
The bank attributed the milestone to a string of marquee mandates, including serving as co-financial adviser to Dominion Energy on its roughly $67 billion sale to rival utility NextEra Energy, announced last month, along with other major transactions.
Rise of the Megadeal
Goldman reported that its investment banking fees rose 48%, to $2.8 billion in the first quarter. It’s a reflection of the “K-shaped” M&A market, where megadeals are the dominant force, but deal volumes are declining, and mid-market activity is subdued.
Data compiled by PwC revealed that the global M&A market is on track to reach $4 trillion in 2026, a 13% annual increase, with major sales estimated to account for 48% of deal value worldwide, a significant expansion from two years ago.
Advertisement
“Goldman has been the global leader in M&A advisory fees for more than 90 consecutive quarters. The fact that it’s reaping benefits from a moment of megadeal activity simply proves the strength of its franchise,” said Mark Narron, senior director at Fitch Ratings. “However, advisory revenues are generally a small share of total revenues. In 2021, which was Goldman’s record year for advisory, advisory revenues contributed only 10% of total revenues.”
Fitch says it’s difficult to forecast whether Goldman’s advisory revenues will continue to climb, given the cyclical nature of advisory fees and uneven regional M&A trends — with most deal activity still concentrated in the U.S.
Fitch expects M&A activity to be sensitive to market conditions, economic growth, geopolitical events, and interest rates. Global growth is estimated to decelerate to 2.8% this year, according to the latest OECD economic outlook report. Inflationary pressures are rising in advanced and emerging economies due to energy shocks from the Iran conflict. Prices in the G20 economies are expected to climb to 4% in 2026. In a “prolonged disruption” scenario, inflation could rise further, which may prompt hawkish interest rate responses from central banks.
Peter Taberner is a contributing writer based in the U.K.